Lipidio Pharmaceuticals

About:

Lipidio Pharmaceuticals focuses on advancing a molecule to treat diseases associated with excess body fat.

Top Investors: The Foundation for Prader-Willi Research, Alethea Capital Management, 3E Bioventures, John Maraganore, Nancy T. Chang

Description:

Lipidio Pharmaceuticals is a healthcare company that focuses on advancing a molecule to treat diseases associated with excess body fat. It includes non-alcoholic steatohepatitis, Prader-Willi syndrome, and antipsychotic drug-induced weight gain. The company was founded in 2018 and headquartered in San Diego, California.

Total Funding Amount:

$20M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)lipidiopharma.com

Founders:

David Bullough, Gary Atkinson, Gordon Foulkes, Raksha Shah

Number of Employees:

1-10

Last Funding Date:

2022-11-10

IPO Status:

Private

Industries: